IL-10 is one of the cytokines up-regulating the GM-CSF expression in non-small cell lung cancer.

The polymorphisms of IL-10 genes were significantly associated with the occurrence of non-small cell lung cancer

IL-10, but not TNF-alpha, TNF-beta, or IL-6 polymorphisms are associated with lung cancer

interleukin-10 expression by tumour-associated macrophages, but not by tumour cells, may play a role in the progression and prognosis of nonsmall cell lung cancer

These results suggest that IL-10, TNF-alpha and TGF-beta1 gene polymorphisms may affect host susceptibility to lung cancer and the outcome of the patients.

CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer

The galectin-1/IL-10 functional axis is crucial in lung cancer-mediated immune suppression, by demonstrating that galectin-1 can serve as a target in the development of lung cancer immunotherapy.

Our results revealed that TAM with high levels of IL-10 expression may play an important role in the progression of non-small cell lung cancer.

meta-analysis suggested that the IL-10-1082 polymorphism was associated with increased risk of cancer in Asians and lung cancer and non-Hodgkin's lymphoma. [Meta-analysis]

A significant association between IL-10 polymorphism and lung cancer risk.

Quantitative analysis showed high concentrations of IL-10 and IL-17 in pleural fluid and blood of lung cancer patients. Statistical correlation between blood and pleural concentations was proven.

IL-10 production from lung tumors and immune cells promotes lung adenocarcinoma aggressiveness and patients with poor survival

The CC and TC genotypes of IL-10 T-819C compared to the TT genotype may have a protective effect on lung cancer risk in Taiwan, particularly among males and smokers.

IFNgamma+874 A/T and IL10-1082 G/G gene polymorphisms were found to be significantly associated with non-small cell lung cancer with 1.56- and 1.68-fold disease risk, respectively.

IL-10 mRNA levels in peripheral B cells were significantly higher in lung cancer patients.A negative correlation was identified between miR-98 and IL-10 in peripheral B cells.

the sensitivity and specificity of CEA, CA125, and ProGRP when used in combination with IL-6, IL-10, and MCP in lung cancer diagnosis, was examined.

IL10 and TGFb1 in systemic and tumor microcirculation are significantly associated with particular histological type of lung cancer, tumor size and degree of disease extent.

These findings support that there is a direct correlation between cytokines including interleukin-6, interleukin-8, interleukin-10, and tumor necrosis factor-alpha and cardiopulmonary bypass time, duration of operation, and intensive care unit stay.

IL-10 -592A>C polymorphism might be risk factor for lung cancer (meta analysis).

The potential influences of IL-10, IL-18 and IL-12 polymorphisms on non-small cell lung cancer (NSCLC) risk were explored in this study.

IL-10 suppresses IFN-gamma-mediated signaling in lung adenocarcinoma.

Il-10 deficiency is associated with lung tumor susceptibility

These results indicate that a primary effect of IL-10 on lung cancer cells may be to increase their metastatic potential by promoting angiogenesis and resistance to apoptosis.

activation of TLR4 signaling pathway in lung cancer cells may be involved in tumor escape and progression by promoting the expression of TGF-beta1 and IL-10 and tumor cells migration

Umbelliprenin induced production of IFN-gamma and TNF-alpha, and reduced IL-10, IL-4, Foxp3 and TGF-beta in a mouse model of lung cancer.

High IL10 expression is associated with lung cancer.